Product
Cohort 1
3 clinical trials
5 indications
Indication
Pemphigus FoliaceusIndication
Pemphigus vulgarisIndication
Celiac DiseaseIndication
Mucopolysaccharidosis Type IIIndication
Metabolic DiseasesClinical trial
A Phase I, Open-Label, Multicenter Trial Exploring the Safety and Tolerability of Autologous Polyclonal Regulatory T Cell Therapy in Adults With Active Pemphigus (APG01)Status: Terminated, Estimated PCD: 2020-12-10
Clinical trial
A Phase 1B Open-label/Phase 2 Double-blind Placebo- Controlled Study for Pharmacodynamic (PD) Activity, Pharmacokinetics (PK), Safety, and Tolerability of KAN-101 In Patients With Celiac Disease (CeD)Status: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Open-label Multi-cohort Study of the Tolerability, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers After a Single Intravenous Injection in Increasing DosesStatus: Completed, Estimated PCD: 2023-09-20